1.
Absolute contraindication for fibrinolytic therapy is
2.
Fibrinolytic agent having antigenic property is
3.
Antidote used to reverse the effects of dabigatran in case of excessive bleeding is
4.
Glycoprotein IIb/IIIa receptor antagonist used in percutaneous coronary interventions is
5.
Which of the following can increase the risk of bleeding in patients taking warfarin?
6.
Lipid-lowering drug class causing fat-soluble vitamin deficiencies is
7.
Lipid-lowering agent/s NOT recommended in patients with severe hypertriglyceridemia (triglyceride levels >500 mg/dL) is
8.
Drug commonly used in combination with aspirin for dual antiplatelet therapy (DAPT) in patients with coronary artery disease is
9.
Preferred anticoagulant to use during pregnancy is
10.
Administration of which of the following anticoagulants does NOT require routine monitoring of blood coagulation parameters?
11.
Omega-3 fatty acids most effectively reduce
12.
Drug used to treat pernicious anemia is
13.
Drug often used to treat anemia associated with chronic kidney disease is
14.
Antifibrinolytic agent among the following is
15.
Drug used in the treatment of heparin-induced thrombocytopenia (HIT) is
17.
NOT a recommended route of administration for tranexamic acid
18.
Statin with least CYP450 enzyme interactions is
19.
Most common indication of fibrinolytic therapy is
20.
Side effect commonly associated with oral iron therapy is